Abbvie Inc.
Abbvie Inc. (United States) holds 7 active US FDA Type II Drug Master Files and 8 inactive, has DMF or CEP filings on record for 13 active ingredients and is linked to 12 FDA-registered manufacturing sites. 18 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Abbvie Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/abbvie-inc
Overview
AbbVie Inc. is a global, research-based biopharmaceutical company that develops and markets therapies for serious health challenges. Known for its innovative approach, AbbVie focuses on areas including immunology, oncology, virology, and neuroscience.
Core services & business areas
Therapeutic areas
Active ingredients with DMF or CEP filings
Substances for which Abbvie Inc. holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
Abbvie Inc. holds 7 active (15 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- ERYTHROMYCIN BASEActive2015-11-10
- PARICALCITOL DRUG SUBSTANCEActive2010-11-30
- ERYTHROMYCIN STEARATEActive1998-09-01
- CYCLOSPORINE USPActive1998-09-01
- ERYTHROMYCIN ETHYLSUCCINATEActive1998-09-01
- ERYTHROMYCIN BASEActive1998-04-30
- BUTORPHANOL TARTRATEActive1990-12-20
- NIACIN CORE TABLET INTERMEDIATEInactive2008-10-31
- CHOLINE FENOFIBRATE MINI-TABLET INTERMEDIATEInactive2007-11-13
- CHOLINE FENOFIBRATE DRUG SUBSTANCEInactive2007-11-13
- 5-DESOSAMINYL-6-0-METHYL ERYTHRONOLIDEInactive1999-12-22
- ERYTHROMYCIN BASEInactive1998-09-01
- CLINDAMYCIN PHOSPHATEInactive1998-09-01
- CLORAZEPATE DIPOTASSIUM (TRANXENE)Inactive1982-05-07
- PRAMOXINE HCLInactive1982-04-30
Registered manufacturing sites (12)
Physical sites registered with the US FDA and resolved to Abbvie Inc., with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
- AbbVie Bioresearch CenterWorcester, United States · API manufacture
- AbbVie Biotechnology GmbHLudwigshafen, Germany · Analytical testingSite GMP match
- AbbVie Biotechnology LTDBarceloneta, United States · API manufacture
- AbbVie Deutschland GmbH & Co KGLudwigshafen, Germany · Analytical testing · LabellingSite GMP match
- AbbVie Inc.North Chicago, United States · Analytical testing · LabellingSite GMP match
- AbbVie Inc.Wyandotte, United States · API manufacture
- AbbVie Inc.North Chicago, United States · API manufactureSite GMP match
- AbbVie Ireland NL B.V.Co Sligo -, Ireland · API manufacture
- AbbVie Ireland NL. B.V.Sligo, Ireland · Drug manufactureSite GMP match
- AbbVie Operations Singapore Pte. Ltd.Singapore, Singapore · API manufactureSite GMP match
- AbbVie SRLCampoverde di Aprilia, Italy · API manufactureSite GMP match
- Fournier Laboratories Ireland LimitedCARRIGTWOHILL, Ireland · Analytical testing · Drug manufactureSite GMP match
FDA compliance signals
18 FDA enforcement records linked to this company.
- recall — Class III2026-06-03
Failed Stability Specifications
- recall — Class II2024-10-02
Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.
- recall — Class II2024-10-02
Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.
- recall — Class III2023-11-15
Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose.
- 4832018-07-02
Late submission of 15-day report
- recall — Class III2018-02-07
Defective container: presence of a hole in the liners of the caps covering the product bottle, introducing possibility of leakage.
- recall — Class III2017-11-01
Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.
- recall — Class III2017-11-01
Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.
- recall — Class II2017-03-08
Failed Stability Specifications: confirmed out of specification results obtained during refrigerated material stability testing indicating that drug may settle within drug cassettes nearing the end of their refrigerated shelf-life
- recall — Class III2016-04-27
Failed Content Uniformity Specifications
- 4832015-08-06
Procedures to be written and followed
- recall — Class II2014-10-08
Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.
- recall — Class II2014-05-07
Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
- recall — Class II2014-05-07
Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
- recall — Class II2014-05-07
Defective Delivery System: Some Lupron Depot Kits may containin a syringe with a potentially defective LuproLoc needle stick protection device.
- recall — Class II2014-05-07
Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
- recall — Class II2014-05-07
Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
- recall — Class III2013-08-28
Labeling: Incorrect Package Insert; product packaged with outdated version of the insert
Is this Abbvie Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.